Voloridge Investment Management
CINC

Voloridge Investment Management’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Voloridge Investment Management’s Portfolio CINC Stock Details CINC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-77,789
Closed -$956K – 1689
2022
Q4 		$956K Buy
+77,789
New +$1.85M 0.01% 1140

Voloridge Investment Management's CINC Position: Q1 2023 in Review

Voloridge Investment Management sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 77,789 shares — an estimated $956K sold.

Voloridge Investment Management first reported a position in CINC in Q4 2022 and held it in 1 quarter. The position peaked at $956K in Q4 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

  • Voloridge Investment Management reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Voloridge Investment Management sold 77,789 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $956K.
  • Voloridge Investment Management first reported a position in CinCor Pharma, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
  • Voloridge Investment Management's CinCor Pharma, Inc. Common Stock position peaked at $956K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Voloridge Investment Management's 13F filing for Q1 2023, filed 15 May 2023.